Table III.
Risk Markers During Baseline and at Follow‐Up
| biogenic risk markers | baseline mean± SD, median (IQR) | 12 months mean± SD, median (IQR) | P value vs baseline (t test) |
|---|---|---|---|
| Albumin/creatinine ratio, mg/g | 52.1±196.3, 9.90 (5.76–25.52) | 49.0±315.7, 9.15 (5.13–20.92) | .7453 |
| hsCRP, mg/L | 4.6±8.7, 2.46 (1.16–5.14) | 4.1±7.5, 2.01 (1.00–4.38) | .1031 |
| NT‐proBNP, pg/mL | 218.8±552.3, 89.28 (38.63–203.40) | 217.0±620.3, 85.69 (34.93–187.00) | .9335 |
Abbreviations: hsCRP, high‐sensitivity C‐reactive protein; IQR, interquartile range; NT‐proBNP, N‐terminal pro‐brain natriuretic peptide; SD, standard deviation.